Insider Trading Alert - Rite Aid Corporation And 4 Others Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Oct. 1, 2013, 71 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $4.49 to $3,242,400,000.00.

Highlighted Stocks Traded by Insiders:

Rite Aid Corporation (RAD) - FREE Research Report

Green Equity Investors Iii Lp who is Affiliate of director at Rite Aid Corporation sold 34.0 million shares at $4.49 on Oct. 1, 2013. Following this transaction, the Affiliate of director owned 6.0 million shares meaning that the stake was reduced by 85% with the 34.0 million share transaction.

Baumer John M who is Director at Rite Aid Corporation sold 34.0 million shares at $4.49 on Oct. 1, 2013. Following this transaction, the Director owned 6.0 million shares meaning that the stake was reduced by 85% with the 34.0 million share transaction.

The shares most recently traded at $5.00, up $0.51, or 10.2% since the insider transaction. Historical insider transactions for Rite Aid Corporation go as follows:

  • 4-Week # shares bought: 40.0 million
  • 12-Week # shares bought: 40.0 million
  • 12-Week # shares sold: 158,554
  • 24-Week # shares bought: 40.0 million
  • 24-Week # shares sold: 40.7 million

The average volume for Rite Aid Corporation has been 21.8 million shares per day over the past 30 days. Rite Aid Corporation has a market cap of $4.5 billion and is part of the services sector and retail industry. Shares are up 263.24% year to date as of the close of trading on Tuesday.

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company has a P/E ratio of 15.4. Currently there is 1 analyst that rates Rite Aid Corporation a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RAD - FREE

TheStreet Quant Ratings rates Rite Aid Corporation as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we find that the company's profit margins have been poor overall. Get the full Rite Aid Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Adobe Systems (ADBE) - FREE Research Report

Garrett Mark who is EVP, CFO & Asst. Secretary at Adobe Systems sold 15,000 shares at $51.98 on Oct. 1, 2013. Following this transaction, the EVP, CFO & Asst. Secretary owned 34,746 shares meaning that the stake was reduced by 30.15% with the 15,000 share transaction.

The shares most recently traded at $51.71, down $0.27, or 0.52% since the insider transaction. Historical insider transactions for Adobe Systems go as follows:

  • 4-Week # shares sold: 15,000
  • 12-Week # shares sold: 30,738
  • 24-Week # shares sold: 46,613

The average volume for Adobe Systems has been 3.2 million shares per day over the past 30 days. Adobe Systems has a market cap of $25.8 billion and is part of the technology sector and computer software & services industry. Shares are up 36.47% year to date as of the close of trading on Tuesday.

Adobe Systems Incorporated operates as a diversified software company worldwide. The company operates in three segments: Digital Media, Digital Marketing, and Print and Publishing. The company has a P/E ratio of 58.4. Currently there are 11 analysts that rate Adobe Systems a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ADBE - FREE

TheStreet Quant Ratings rates Adobe Systems as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Adobe Systems Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

International Paper (IP) - FREE Research Report

Faraci John V who is Chairman and CEO at International Paper sold 10,000 shares at $45.00 on Oct. 1, 2013. Following this transaction, the Chairman and CEO owned 1.6 million shares meaning that the stake was reduced by 0.62% with the 10,000 share transaction.

The shares most recently traded at $44.74, down $0.26, or 0.58% since the insider transaction. Historical insider transactions for International Paper go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 30,000
  • 24-Week # shares sold: 135,709

The average volume for International Paper has been 3.1 million shares per day over the past 30 days. International Paper has a market cap of $21.0 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 18.07% year to date as of the close of trading on Tuesday.

International Paper Company operates as a paper and packaging company in North America, Europe, Latin America, Russia, Asia, and North Africa. The stock currently has a dividend yield of 2.98%. The company has a P/E ratio of 21.4. Currently there are 12 analysts that rate International Paper a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on IP - FREE

TheStreet Quant Ratings rates International Paper as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, revenue growth, growth in earnings per share and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full International Paper Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Covidien (COV) - FREE Research Report

Green Eric C who is Vice President at Covidien sold 3,440 shares at $60.84 on Oct. 1, 2013. Following this transaction, the Vice President owned 20,093 shares meaning that the stake was reduced by 14.62% with the 3,440 share transaction.

The shares most recently traded at $60.66, down $0.18, or 0.3% since the insider transaction. Historical insider transactions for Covidien go as follows:

  • 4-Week # shares sold: 16,200
  • 12-Week # shares sold: 16,591
  • 24-Week # shares sold: 35,771

The average volume for Covidien has been 2.3 million shares per day over the past 30 days. Covidien has a market cap of $28.5 billion and is part of the health care sector and health services industry. Shares are up 7.27% year to date as of the close of trading on Tuesday.

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. The stock currently has a dividend yield of 2.07%. The company has a P/E ratio of 15.5. Currently there are 13 analysts that rate Covidien a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on COV - FREE

TheStreet Quant Ratings rates Covidien as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures, notable return on equity and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Covidien Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Stryker Corporation (SYK) - FREE Research Report

Stryker Ronda E who is Director at Stryker Corporation sold 14,000 shares at $67.86 on Oct. 1, 2013. Following this transaction, the Director owned 11.7 million shares meaning that the stake was reduced by 0.12% with the 14,000 share transaction.

The shares most recently traded at $68.04, up $0.18, or 0.26% since the insider transaction. Historical insider transactions for Stryker Corporation go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 2,000
  • 24-Week # shares sold: 28,000

The average volume for Stryker Corporation has been 1.2 million shares per day over the past 30 days. Stryker Corporation has a market cap of $26.8 billion and is part of the health care sector and health services industry. Shares are up 29.2% year to date as of the close of trading on Tuesday.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. The stock currently has a dividend yield of 1.5%. The company has a P/E ratio of 23.8. Currently there are 13 analysts that rate Stryker Corporation a buy, 1 analyst rates it a sell, and 12 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SYK - FREE

TheStreet Quant Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

General Electric Booted From Dow, Replaced by Walgreens

General Electric Booted From Dow, Replaced by Walgreens